Product Code: AST 9317
The global laboratory freezers market is projected to reach USD 5.11 billion by 2031 from USD 4.32 billion in 2026, at a CAGR of 3.5% from 2026 to 2031.
| Scope of the Report |
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Product, Application, End User, and Region |
| Regions covered | North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa |
The laboratory freezers market is primarily driven by the increasing need for reliable, temperature-controlled storage of vaccines, biological samples, reagents, blood components, cell lines, tissues, and other temperature-sensitive materials. The rapid expansion of pharmaceutical and biotechnology research, vaccine development, clinical diagnostics, biobanking, genomics, and cell and gene therapy is accelerating the adoption of advanced laboratory freezers across research institutes, hospitals, diagnostic laboratories, pharmaceutical companies, and biobanks. In addition, stringent regulatory and quality requirements for maintaining sample integrity and cold-chain compliance are encouraging end users to adopt freezers equipped with precise temperature control, continuous monitoring, automated data logging, remote alarms, and backup systems.

Furthermore, increasing investments in healthcare and life-science infrastructure, the expansion of biorepositories, and growing demand for ultra-low-temperature storage are supporting market growth. Manufacturers are also introducing energy-efficient compressors, environmentally sustainable refrigerants, improved insulation, automated inventory management, and IoT-enabled monitoring systems to reduce operating costs, minimize sample-loss risks, and enhance laboratory workflow efficiency, thereby driving sustained growth of the laboratory freezers market.
"By product, refrigerators accounted for the largest share of the laboratory freezers market in 2025."
By product, the laboratory freezers market is segmented into freezers, refrigerators, and cryopreservation systems. Refrigerators account for the largest market share due to their widespread use for the routine storage of vaccines, reagents, culture media, pharmaceutical products, blood samples, and other temperature-sensitive materials at controlled temperatures, typically between 2°C and 8°C. Their extensive installation across hospitals, diagnostic laboratories, blood banks, pharmacies, research institutes, and pharmaceutical and biotechnology companies generates strong and recurring demand. Compared with ultra-low-temperature freezers and cryopreservation systems, laboratory refrigerators offer lower acquisition and operating costs, simpler maintenance, and broader applicability in everyday laboratory workflows. Furthermore, expanding diagnostic testing, vaccine programs, clinical research, and pharmaceutical production-along with stringent requirements for temperature stability, continuous monitoring, automated data logging, and regulatory compliance are supporting the segment's leading position. Growing adoption of energy-efficient, environmentally sustainable, and IoT-enabled refrigerators with remote alarms and backup controls is expected to further drive segment growth.
"By application, the pharmaceutical & vaccine storage segment accounted for the largest share of the laboratory freezers market."
By application, the laboratory freezers market is segmented into environmental testing, genetic material storage, pharmaceutical & vaccine storage, biological samples & inventory management, and other applications. The pharmaceutical & vaccine storage segment accounted for the largest market share owing to the substantial volume of temperature-sensitive vaccines, biologics, drugs, active pharmaceutical ingredients, reagents, and clinical-trial materials requiring controlled storage. The expansion of vaccine manufacturing and immunization programs, increasing production of biologics and specialty medicines, and growth in pharmaceutical research and clinical trials are creating strong demand for laboratory refrigerators and freezers. Furthermore, stringent regulatory requirements for temperature stability, continuous monitoring, data logging, alarm systems, backup power, and cold-chain compliance encourage pharmaceutical manufacturers, hospitals, pharmacies, research laboratories, and distribution centers to invest in reliable storage equipment. The recurring need to store pharmaceutical products across research, production, quality-control, and distribution workflows further reinforces the segment's leading market position.
By end user, pharmaceutical & biotechnology companies accounted for the largest share in the forecast period.
By end user, the laboratory freezers market is segmented into hospitals, clinical & pathology laboratories, pharmaceutical & biotechnology companies, academic & research institutes, pharmacies & physicians' offices, and cell & tissue banks. Pharmaceutical & biotechnology companies accounted for the largest market share due to their extensive requirement for controlled-temperature storage across drug discovery, vaccine development, biologics manufacturing, clinical trials, quality control, and commercial production. These companies store substantial volumes of temperature-sensitive materials, including vaccines, biologics, cell lines, genetic material, reagents, active pharmaceutical ingredients, reference standards, and clinical-trial samples. Rising investment in biopharmaceutical R&D, expanding biologics and biosimilar pipelines, and the development of cell and gene therapies are further increasing demand for refrigerators, ultra-low-temperature freezers, and cryopreservation systems. Moreover, stringent regulatory requirements for sample integrity, temperature monitoring, data logging, alarm management, backup systems, and storage validation support the segment's leading market position.
"The Asia Pacific market is projected to show the highest growth rate in the laboratory freezers market."
The laboratory freezers market spans five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to register the highest growth rate, driven by the rapid expansion of pharmaceutical and biotechnology manufacturing, vaccine production, clinical research, diagnostic testing, and biobanking activities. Increasing healthcare expenditure, government investments in life-science infrastructure, and the establishment of new research laboratories, hospitals, and cold-chain facilities are strengthening demand for laboratory refrigerators, ultra-low-temperature freezers, and cryopreservation systems. The region is also benefiting from the growing production of biologics, biosimilars, and cell and gene therapies, particularly in China, India, Japan, and South Korea. Furthermore, increasing awareness of sample integrity, stricter temperature-control requirements, and rising adoption of energy-efficient and digitally connected storage systems are expected to accelerate regional market growth.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
- By Designation: Directors (50%), Managers (30%), and Others (20%)
- By Region: North America (37%), Europe (25%), Asia Pacific (30%), Latin America (5%), and the Middle East & Africa (3%)
The major players in the laboratory freezers market include Thermo Fisher Scientific (US), Haier Biomedical (China), PHC Holdings (Japan), Eppendorf AG (Germany), and Avantor (US), among others
Research Coverage
The research report examines the laboratory freezers market by product, application, end user, and region. This research covers factors driving market expansion, analyzes prospects and parameters faced by industries today, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micromarket analysis
Reasons to Buy the Report
The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall laboratory freezers market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities.
This report provides insightful data on the following pointers:
- Market Penetration: In-depth coverage of product portfolios offered by the top players in the laboratory freezers market
- Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the laboratory freezers market
- Market Development: Insightful data on profitable developing areas
- Market Diversification: Details about recent developments and advancements in the laboratory freezers market
- Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 DISRUPTIVE TRENDS IN LABORATORY FREEZERS MARKET
- 2.3 HIGH GROWTH SEGMENTS
- 2.4 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 LABORATORY FREEZERS MARKET OVERVIEW
- 3.2 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY COUNTRY AND PRODUCT, 2025
- 3.3 GEOGRAPHIC SNAPSHOT OF LABORATORY FREEZERS MARKET
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Expanding life science research and temperature-sensitive biologics storage
- 4.2.1.2 Expanding vaccine and biopharmaceutical production drives demand for validated frozen-storage infrastructure
- 4.2.2 RESTRAINTS
- 4.2.2.1 High capital and lifecycle costs of advanced freezers
- 4.2.2.2 Tightening refrigerant regulations that increase compliance costs
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Transition to natural-refrigerant and HFC-free cooling technologies
- 4.2.3.2 Growing clinical-trial activity to expand decentralized sample-storage requirements
- 4.2.4 CHALLENGES
- 4.2.4.1 Maintaining temperature uniformity and sample integrity
- 4.2.4.2 Stringent validation and documentation requirements
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 BARGAINING POWER OF BUYERS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF NEW ENTRANTS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 GDP TRENDS AND FORECAST
- 5.2.2 TRENDS IN GLOBAL LABORATORY FREEZERS INDUSTRY
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.3.1 PROMINENT COMPANIES
- 5.3.2 SMALL AND MEDIUM-SIZED ENTERPRISES
- 5.3.3 END USERS
- 5.4 VALUE CHAIN ANALYSIS
- 5.4.1 RESEARCH & DEVELOPMENT
- 5.4.2 RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT
- 5.4.3 MARKETING, SALES, AND DISTRIBUTION
- 5.5 ECOSYSTEM ANALYSIS
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE OF LABORATORY FREEZERS, BY KEY PLAYER, 2025
- 5.6.2 AVERAGE SELLING PRICE OF PRODUCT, BY KEY PLAYER, 2023-2025 (USD)
- 5.6.3 AVERAGE SELLING PRICE TREND, BY REGION, 2025
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT DATA FOR HS CODE 841840
- 5.7.2 IMPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE, OF A CAPACITY <= 900 L (HS CODE 841840)
- 5.7.3 EXPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE, OF A CAPACITY <= 900 L (HS CODE 841840)
- 5.8 KEY CONFERENCES & EVENTS, 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.9.1 DIGITAL MONITORING, SUSTAINABILITY, AND EXPANDING APPLICATIONS TRANSFORM MARKET
- 5.10 INVESTMENT & FUNDING SCENARIO
- 5.11 CASE STUDY ANALYSIS
- 5.12 IMPACT OF 2025 US TARIFF ON LABORATORY FREEZERS MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 KEY TARIFF RATES
- 5.12.3 KEY TARIFF RATES
- 5.12.4 PRICE IMPACT ANALYSIS
- 5.12.5 IMPACT ON COUNTRY/REGION
- 5.12.5.1 US
- 5.12.5.2 Europe
- 5.12.5.3 Asia Pacific
- 5.12.6 IMPACT ON END USERS
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 NATURAL/ECO-FRIENDLY REFRIGERANTS
- 6.1.2 SMART/IOT-ENABLED FREEZERS
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 TEMPERATURE-CONTROLLED TRANSPORT SYSTEMS
- 6.2.2 BUILDING-MANAGEMENT-SYSTEM INTEGRATION
- 6.2.3 ROBOTIC AND AUTOMATED SAMPLE-STORAGE SYSTEMS
- 6.3 PATENT ANALYSIS
- 6.4 IMPACT OF AI/GEN AI ON LABORATORY FREEZERS MARKET
- 6.4.1 TOP USE CASES AND MARKET POTENTIAL
- 6.4.2 BEST PRACTICES IN LABORATORY FREEZERS
- 6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN LABORATORY FREEZERS MARKET
- 6.4.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
- 6.4.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN LABORATORY FREEZERS MARKET
- 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7 REGULATORY LANDSCAPE
- 7.1 REGULATORY TRENDS
- 7.1.1 NORTH AMERICA
- 7.1.1.1 US
- 7.1.1.2 Canada
- 7.1.2 EUROPE
- 7.1.3 ASIA PACIFIC
- 7.1.3.1 Japan
- 7.1.3.2 China
- 7.1.3.3 India
- 7.2 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.2.1 NORTH AMERICA
- 7.2.2 EUROPE
- 7.2.3 ASIA PACIFIC
- 7.2.4 LATIN AMERICA
- 7.2.5 MIDDLE EAST & AFRICA
- 7.3 INDUSTRY STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 KEY STAKEHOLDERS & BUYING CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA
- 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
- 8.4 UNMET NEEDS OF VARIOUS END USERS
9 LABORATORY FREEZERS MARKET, BY PRODUCT
- 9.1 INTRODUCTION
- 9.2 FREEZERS
- 9.2.1 ULTRA-LOW-TEMPERATURE FREEZERS
- 9.2.1.1 Expanding biobanking and cell & gene therapy pipelines drive demand
- 9.2.2 GENERAL-PURPOSE FREEZERS
- 9.2.2.1 Increased clinical and diagnostic test volume to drive market growth
- 9.2.3 PLASMA FREEZERS
- 9.2.3.1 Rising blood component demand and trauma care needs sustain segment growth
- 9.2.4 ENZYME FREEZERS
- 9.2.4.1 Expansion of biotechnology research and enzyme-based diagnostics to drive demand
- 9.2.5 EXPLOSION-PROOF FREEZERS
- 9.2.5.1 Tightening laboratory safety codes accelerate adoption of hazardous-location freezer design
- 9.2.6 FLAMMABLE MATERIAL FREEZERS
- 9.2.6.1 Expanding chemical inventories in research and pharma labs boost demand for dedicated flammable storage
- 9.3 REFRIGERATORS
- 9.3.1 BLOOD BANK REFRIGERATORS
- 9.3.1.1 Growing blood donation networks and trauma caseloads fuel demand
- 9.3.2 CHROMATOGRAPHY REFRIGERATORS
- 9.3.2.1 Precision temperature control for analytical workflows expand segment
- 9.3.3 EXPLOSION-PROOF REFRIGERATORS
- 9.3.3.1 Hazardous-location certification needs enhance demand in R&D labs
- 9.3.4 FLAMMABLE MATERIAL REFRIGERATORS
- 9.3.4.1 Stricter chemical safety compliance drives lab upgrades
- 9.3.5 LABORATORY REFRIGERATORS
- 9.3.5.1 Energy-efficient lab refrigerator to grow market
- 9.3.6 PHARMACY REFRIGERATORS
- 9.3.6.1 Expansion of pharmacy-based vaccination services drives purpose-built cold storage demand
- 9.4 CRYOPRESERVATION SYSTEMS
- 9.4.1 NEED FOR APPROPRIATE CRYOPRESERVATION STORAGE SYSTEMS TO ENSURE SAMPLE INTEGRITY BOOSTS SEGMENT GROWTH
10 LABORATORY FREEZERS MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 ENVIRONMENTAL TESTING
- 10.2.1 REFORMS IN ENVIRONMENTAL TESTING NORMS TO DRIVE DEMAND
- 10.3 GENETIC MATERIAL STORAGE
- 10.3.1 INCREASED RESEARCH INVESTMENTS IN OMICS RESEARCH TO DRIVE MARKET GROWTH
- 10.4 PHARMACEUTICAL & VACCINE STORAGE
- 10.4.1 TEMPERATURE-SENSITIVE REQUIREMENTS IN DRUG AND VACCINE MANUFACTURING TO DRIVE SEGMENT
- 10.5 BIOLOGICAL SAMPLES & INVENTORY MANAGEMENT
- 10.5.1 GROWTH IN SAMPLE VOLUME TO DRIVE DEMAND FOR REFRIGERATORS
- 10.6 OTHER APPLICATIONS
- 10.6.1 RAPID-RESPONSE COLD STORAGE DRIVING REPLACEMENT DEMAND ACROSS BLOOD BANKS AND TRANSFUSION SERVICES
11 LABORATORY FREEZERS MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 HOSPITALS
- 11.2.1 RAPID-RESPONSE COLD STORAGE DRIVES REPLACEMENT DEMAND ACROSS EMERGENCY, ONCOLOGY, AND SURGICAL CARE
- 11.3 CLINICAL & PATHOLOGY LABORATORIES
- 11.3.1 DIGITAL PATHOLOGY AND AUTOMATION TO DRIVE MARKET GROWTH IN CLINICAL LABORATORIES
- 11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 11.4.1 GMP-COMPLIANT ULTRA-LOW TEMPERATURE STORAGE SCALING TO DRIVE GROWTH
- 11.5 ACADEMIC & RESEARCH INSTITUTES
- 11.5.1 GREEN-LAB AND ENERGY-REDUCTION INITIATIVES RESHAPING FREEZER PROCUREMENT AND OPERATING PRACTICES
- 11.6 PHARMACIES & PHYSICIANS' OFFICES
- 11.6.1 COMPLIANCE REQUIREMENTS FOR CHILDREN'S VACCINES TO BOOST SEGMENT
- 11.7 CELL & TISSUE BANKS
- 11.7.1 INCREASED ADOPTION OF FREEZERS IN MOLECULAR DIAGNOSTICS TO DRIVE MARKET EXPANSION
- 11.8 ENVIRONMENTAL LABS
- 11.8.1 INCREASED ADOPTION DUE TO STRICTER ENVIRONMENTAL MONITORING PROGRAMS
- 11.9 FORENSIC LABS
- 11.9.1 COLD-CASE RETESTING AND DNA EVIDENCE INTEGRITY REINFORCE LONG-TERM FROZEN STORAGE PROTOCOLS
- 11.10 FOOD & BEVERAGE COMPANIES
- 11.10.1 STRICT QUALITY CONTROL REQUIREMENTS TO DRIVE DEMAND
- 11.11 OTHER END USERS
- 11.11.1 LONG-TERM SAMPLE PRESERVATION TO DRIVE MARKET GROWTH IN OTHER END USERS
12 LABORATORY FREEZERS MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 US
- 12.2.1.1 Established biopharma & R&D landscape to drive replacement cycle
- 12.2.2 CANADA
- 12.2.2.1 Growth in pharmaceutical R&D sector to grow demand for cold storage technologies
- 12.3 EUROPE
- 12.3.1 GERMANY
- 12.3.1.1 Strong local manufacturing footprints and established research infrastructure to drive market growth
- 12.3.2 UK
- 12.3.2.1 UKRI investments and national research infrastructure to fuel lab freezers adoption
- 12.3.3 FRANCE
- 12.3.3.1 Large research & development base to grow demand for cold storage samples
- 12.3.4 ITALY
- 12.3.4.1 Industry-academia partnership to drive market growth
- 12.3.5 SPAIN
- 12.3.5.1 Large clinical research base to drive freezer demand
- 12.3.6 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 JAPAN
- 12.4.1.1 Increased investments in pharma manufacturing to drive market
- 12.4.2 CHINA
- 12.4.2.1 National GeneBank expansion and localized manufacturing scale to drive market growth
- 12.4.3 INDIA
- 12.4.3.1 National phenome and genome project to scale up demand for cold storage equipment
- 12.4.4 AUSTRALIA
- 12.4.4.1 Strong biobank network to drive demand cold storage options in Australia
- 12.4.5 SOUTH KOREA
- 12.4.5.1 Academic and medical institutes to drive demand for laboratory refrigeration solutions
- 12.4.6 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 BRAZIL
- 12.5.1.1 Fiocruz biobank network and regional manufacturing base - key drivers
- 12.5.2 MEXICO
- 12.5.2.1 Expansion in biopharmaceutical sector to boost market
- 12.5.3 REST OF LATIN AMERICA
- 12.6 MIDDLE EAST & AFRICA
- 12.6.1 GCC COUNTRIES
- 12.6.1.1 Government-led investments to grow market in GCC countries
- 12.6.2 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
- 13.1 INTRODUCTION
- 13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023-2026
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LABORATORY FREEZERS MARKET
- 13.3 REVENUE ANALYSIS, 2021-2025
- 13.4 MARKET SHARE ANALYSIS, 2025
- 13.4.1 MARKET RANKING OF KEY PLAYERS, 2025
- 13.5 COMPANY VALUATION AND FINANCIAL METRICS
- 13.5.1 FINANCIAL METRICS
- 13.5.2 COMPANY VALUATION
- 13.6 BRAND/PRODUCT COMPARISON
- 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 13.7.1 STARS
- 13.7.2 EMERGING LEADERS
- 13.7.3 PERVASIVE PLAYERS
- 13.7.4 PARTICIPANTS
- 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 13.7.5.1 Company footprint
- 13.7.5.2 Region footprint
- 13.7.5.3 Product footprint
- 13.7.5.4 Application footprint
- 13.7.5.5 End user footprint
- 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 13.8.1 PROGRESSIVE COMPANIES
- 13.8.2 RESPONSIVE COMPANIES
- 13.8.3 DYNAMIC COMPANIES
- 13.8.4 STARTING BLOCKS
- 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 13.8.5.1 Detailed list of key startups/SMEs
- 13.8.5.2 Competitive benchmarking of key startups/SMEs
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 THERMO FISHER SCIENTIFIC INC.
- 14.1.1.1 Business overview
- 14.1.1.2 Products offered
- 14.1.1.3 Recent developments
- 14.1.1.3.1 Product launches
- 14.1.1.3.2 Expansions
- 14.1.1.4 MnM view
- 14.1.1.4.1 Right to win
- 14.1.1.4.2 Strategic choices
- 14.1.1.4.3 Weaknesses & competitive threats
- 14.1.2 HAIER BIOMEDICAL
- 14.1.2.1 Business overview
- 14.1.2.2 Products offered
- 14.1.2.3 Recent developments
- 14.1.2.3.1 Product launches
- 14.1.2.3.2 Deals
- 14.1.2.4 MnM view
- 14.1.2.4.1 Right to win
- 14.1.2.4.2 Strategic choices
- 14.1.2.4.3 Weaknesses & competitive threats
- 14.1.3 PHC HOLDINGS CORPORATION
- 14.1.3.1 Business overview
- 14.1.3.2 Products offered
- 14.1.3.3 Recent developments
- 14.1.3.3.1 Product launches
- 14.1.3.4 MnM view
- 14.1.3.4.1 Right to win
- 14.1.3.4.2 Strategic choices
- 14.1.3.4.3 Weaknesses & competitive threats
- 14.1.4 EPPENDORF SE
- 14.1.4.1 Business overview
- 14.1.4.2 Products offered
- 14.1.4.3 Recent developments
- 14.1.4.3.1 Product launches & approvals
- 14.1.4.3.2 Deals
- 14.1.4.3.3 Expansions
- 14.1.4.4 MnM view
- 14.1.4.4.1 Right to win
- 14.1.4.4.2 Strategic choices
- 14.1.4.4.3 Weaknesses & competitive threats
- 14.1.5 AVANTOR, INC.
- 14.1.5.1 Business overview
- 14.1.5.2 Products offered
- 14.1.5.3 Recent developments
- 14.1.6 HELMER SCIENTIFIC
- 14.1.6.1 Business overview
- 14.1.6.2 Products offered
- 14.1.6.3 Recent developments
- 14.1.6.3.1 Product launches & approvals
- 14.1.7 FOLLETT PRODUCTS, LLC
- 14.1.7.1 Business overview
- 14.1.7.2 Products offered
- 14.1.8 LIEBHERR
- 14.1.8.1 Business overview
- 14.1.8.2 Products offered
- 14.1.8.3 Recent developments
- 14.1.8.3.1 Product launches & approvals
- 14.1.9 FELIX STORCH, INC.
- 14.1.9.1 Business overview
- 14.1.9.2 Products offered
- 14.1.10 CUSTOM BIOGENIC SYSTEMS
- 14.1.10.1 Business overview
- 14.1.10.2 Products offered
- 14.1.11 BLUE STAR LIMITED
- 14.1.11.1 Business overview
- 14.1.11.2 Products offered
- 14.1.12 PHILIPP KIRSCH GMBH
- 14.1.12.1 Business overview
- 14.1.12.2 Products offered
- 14.2 OTHER PLAYERS
- 14.2.1 SO-LOW ENVIRONMENTAL EQUIPMENT CO. LTD
- 14.2.2 JEIO TECH
- 14.2.3 STERICOX INDIA PRIVATE LIMITED
- 14.2.4 THALHEIMER KUHLUNG FEZO
- 14.2.5 B MEDICAL SYSTEMS
- 14.2.6 STANDEX INTERNATIONAL CORPORATION
- 14.2.7 EVERMED S.R.L
- 14.2.8 ARCTIKO
- 14.2.9 VESTFROST SOLUTIONS
- 14.2.10 KW TECNILABO
- 14.2.11 COLE PARMER
- 14.2.12 ZHONGKE MEILING CRYOGENICS COMPANY LIMITED
- 14.2.13 ESAW INDIA
15 RESEARCH METHODOLOGY
- 15.1 RESEARCH DATA
- 15.1.1 SECONDARY RESEARCH
- 15.1.1.1 Key secondary sources
- 15.1.1.2 Key data from secondary sources
- 15.1.2 PRIMARY RESEARCH
- 15.1.2.1 Key primary sources
- 15.1.2.2 Key supply- and demand-side participants
- 15.1.2.3 Breakdown of primary interviews
- 15.1.2.4 Key primary insights
- 15.2 MARKET SIZE ESTIMATION METHODOLOGY
- 15.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
- 15.2.2 END-USER-BASED MAPPING MARKET ESTIMATION
- 15.3 GROWTH FORECASTING MODEL
- 15.4 DATA TRIANGULATION AND MARKET BREAKDOWN
- 15.5 RESEARCH ASSUMPTIONS
- 15.6 RESEARCH LIMITATIONS
- 15.7 RISK ANALYSIS
16 APPENDIX
- 16.1 DISCUSSION GUIDE
- 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 16.3 CUSTOMIZATION OPTIONS
- 16.4 RELATED REPORTS
- 16.5 AUTHOR DETAILS